In a word, the dbMCS is an open-access web portal to systemically retrieve the abundant data of mutation markers of anti-cancer drug sensitivity, which will be of great importance for tackling the problem of drug sensitivity prediction and biomarker identification in cancers.
dbMCS: A Database for Exploring the Mutation Markers of Anti-Cancer ...
pubmed.ncbi.nlm.nih.gov › ...
We presented a manually curated online-based database of mutation Markers for anti-Cancer drug Sensitivity (dbMCS).
By comparing the mutations in dbMCS with the putative neutral polymorphisms, we investigated the characteristics of drug sensitivity markers. We found that the ...
dbMCS: a database for exploring the mutation markers of anti-cancer drug sensitivity. IEEE Journal of Biomedical and Health Informatics, 2021, 25( 11): 4229 ...
People also ask
What is the database for cancer research?
What is the database for gene expression in cancer?
What major groups of genes that when mutated can cause cancer and include types of mutations that can change their protein structure?
Here, we developed a comprehensive literature-based database of Cancer Passenger Mutations (dbCPM), which contains 941 experimentally supported and 978 putative ...
Shen et al. dbMCS: A database for exploring the mutation markers of anti-cancer drug sensitivity. IEEE J Biomed Health Inform. (2021). Y. Zhou. Therapeutic ...
On this website, you will find drug response data and genomic markers of sensitivity. e.g. Docetaxel, RP-56976, BRAF, COLO-829. Overview.
Missing: dbMCS: Exploring Anti-
Sep 10, 2024 · dbMCS: A Database for Exploring the Mutation Markers of Anti-Cancer Drug Sensitivity. Article. Jul 2021. Yueyue Shen · Youhua Zhang · Wei Xue ...
No information is available for this page. · Learn why
CancerDR – Cancer Drug Resistance Database provides information about 148 anti-cancer drugs, and their pharmacological profiling across 951 cancer cell lines.
Missing: dbMCS: | Show results with:dbMCS: